AIHealthcare Analytics

Knowledge Wiki

Wiki › FDA Seeks Public Input on Adaptive AI Medical Devices That Can Change Their Answers (2026)

FDA Seeks Public Input on Adaptive AI Medical Devices That Can Change Their Answers (2026)

OVERVIEW
Rev 2 Oct 28, 2026 05:59 UTC 2 sources

The FDA is seeking public input on how to regulate adaptive AI medical devices—systems that change their outputs over time based on real-world performance data. Articles 22 and 23 report the FDA's competency-based approach to generative AI regulation, treating AI like physicians who must earn and maintain competency. Adaptive AI devices present novel regulatory challenges: traditional pre-market approval assumes fixed device behavior, but adaptive systems evolve post-launch. The FDA's framework considers whether AI maintains clinical validity as it learns, how to monitor performance drift, and what triggers require new authorization. Public comments address questions about acceptable performance variation, monitoring frequency, and the role of manufacturers versus health systems in oversight. This regulatory approach reflects FDA's shift toward risk-based, evidence-driven frameworks for AI medical devices. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index